Statements (112)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:government_agency
|
| gptkbp:abbreviation |
gptkb:FDA
|
| gptkbp:approvedBy |
animal drugs
biologics food additives medical devices vaccines new drugs |
| gptkbp:budget |
over $6 billion (2023)
|
| gptkbp:collaboratesWith |
gptkb:Centers_for_Disease_Control_and_Prevention
gptkb:National_Institutes_of_Health gptkb:World_Health_Organization |
| gptkbp:commissioner |
gptkb:Robert_Califf
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:division |
gptkb:Center_for_Biologics_Evaluation_and_Research
gptkb:Center_for_Food_Safety_and_Applied_Nutrition gptkb:Center_for_Tobacco_Products gptkb:Center_for_Veterinary_Medicine gptkb:Office_of_Regulatory_Affairs Center for Devices and Radiological Health Center for Drug Evaluation and Research |
| gptkbp:employs |
over 17,000 people
|
| gptkbp:enforcedBy |
gptkb:Public_Health_Service_Act
gptkb:Federal_Food,_Drug,_and_Cosmetic_Act gptkb:Tobacco_Control_Act |
| gptkbp:founded |
1906
|
| gptkbp:fullName |
gptkb:Food_and_Drug_Administration
|
| gptkbp:headquartersLocation |
gptkb:Silver_Spring,_Maryland
|
| https://www.w3.org/2000/01/rdf-schema#label |
FDA
|
| gptkbp:jurisdiction |
gptkb:Federal_government_of_the_United_States
|
| gptkbp:mission |
ensuring safety of food supply, cosmetics, and products that emit radiation
protecting public health by ensuring safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices |
| gptkbp:oversees |
clinical trials
adverse event reporting food labeling recalls drug labeling |
| gptkbp:parentOrganization |
gptkb:U.S._Department_of_Health_and_Human_Services
|
| gptkbp:regulates |
gptkb:food
gptkb:livestock gptkb:seafood gptkb:water gptkb:COVID-19_treatments gptkb:COVID-19_vaccines antibiotics animal medical devices biologics biosimilars blood products cellular therapies color additives compounded drugs contact lenses cosmetics dietary supplements food contact substances gene therapies generic drugs infant formula investigational new drugs medical devices orphan drugs over-the-counter drugs prescription drugs radiation-emitting products vaccines medical device microwave ovens dairy products packaging produce emergency use authorizations allergenics animal cloning antifungals antiparasitics antivirals artificial intelligence in medical devices biological products bioterrorism countermeasures cell-based products cosmetic labeling cosmetic safety dietary ingredients e-cigarettes genetically engineered animals human cells and tissues mammography equipment mobile medical apps nicotine replacement therapies permanent makeup pharmaceutical drugs pharmacy compounding plasma derivatives rare disease therapies shell eggs tattoo inks tissue products tobacco distribution tobacco manufacturing tobacco marketing tobacco products veterinary products x-ray equipment |
| gptkbp:website |
https://www.fda.gov/
|
| gptkbp:bfsParent |
gptkb:Food_and_Drug_Administration
gptkb:sugar gptkb:U.S._Public_Health_Service_Commissioned_Corps gptkb:vitamin_A gptkb:Class_III gptkb:Butterfly_iQ |
| gptkbp:bfsLayer |
4
|